VRCAVerrica Pharmaceuticals Inc.

$57M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$8M

Net Income

-$7M

EPS (Diluted)

$-3.01

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$780,000

Balance Sheet

Total Assets

$86M

Total Liabilities

$3M

Stockholders' Equity

$83M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$8M	-$2M	-319.1%
Net Income	-$7M	-$2M	-299.1%

VRCA Q1 2019 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena